Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows provided by operating activities
Net income (loss)	$ 2,574,000	$ (1,032,000)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Loss from discontinued operations, net	272,000	1,076,000
Depreciation and amortization expense	1,379,000	935,000
Amortization of deferred finance costs	141,000	80,000
Stock-based compensation	4,640,000	5,151,000
Allowance for doubtful accounts	(21,000)	2,000
Amortization of note discount	406,000	575,000
Deferred income tax benefit	(394,000)	(1,031,000)
Tax benefit from vested stock grants and exercised options	(306,000)	(508,000)
Gain on reduction of contingent obligation	(3,000,000)	(600,000)
Loss on extinguishment of debt	1,371,000	0
Changes in operating assets and liabilities:
Accounts receivable	(3,931,000)	(103,000)
Prepaid expenses and other assets	(187,000)	(46,000)
Accounts payable,accrued expenses and other current liabilities	(217,000)	2,342,000
Deferred revenue	341,000	(235,000)
Other liabilities	119,000	0
Net cash provided by operating activities from continuing operations	3,187,000	6,606,000
Net cash provided by (used in) operating activities from discontinued operations, net	108,000	(739,000)
Net cash provided by operating activities	3,295,000	5,867,000
Cash flows used in investing activities
Cash consideration for asset acquisition of the Ripka Brand	0	(12,365,000)
Cash consideration for asset acquisition of the H Halston Brand	(14,000)	(18,513,000)
Cash consideration for asset acquisition of the C Wonder Brand	(3,587,000)	0
Purchase of property and equipment	(530,000)	(246,000)
Restricted cash for security deposit	(1,109,000)	0
Net cash used in investing activities from continuing operations	(5,240,000)	(31,124,000)
Net cash used in investing activities from discontinued operations, net	0	(433,000)
Net cash used in investing activities	(5,240,000)	(31,557,000)
Cash flows provided by financing activities
Proceeds from issuance of Common Stock, net of direct costs	16,107,000	9,294,000
Proceeds from exercise of stock options	65,000	6,000
Tax benefit from vested stock grants and exercised options	306,000	508,000
Shares repurchased including vested restricted stock in exchange for withholding taxes	(748,000)	(978,000)
Proceeds from term debt related to the Ripka Brand	0	9,000,000
Proceeds from term debt related to the H Brand	0	10,000,000
Payment of contingent obligation	0	(315,000)
Payment of deferred finance costs	(10,000)	(505,000)
Payment of long-term debt	(3,256,000)	(250,000)
Payment of installment obligations related to the acquisition of the Ripka Brand	(2,190,000)	0
Net cash provided by financing activities	10,274,000	26,760,000
Net increase in cash and cash equivalents	8,329,000	1,070,000
Cash and cash equivalents, beginning of year	8,531,000	7,461,000
Cash and cash equivalents, end of year	16,860,000	8,531,000
Supplemental disclosure of non-cash activities:
Issuance of common stock in connection with C Wonder Brand acquisition	9,000,000	0
Contingent obligation related to acquisition of the C Wonder Brand	2,850,000	0
Issuance of Notes payable as partial consideration in the acquisition of the Ripka Brand (net of debt discount - see Note 5)	0	4,165,000
Issuance of common stock in connection with Ripka Brand acquisition	0	2,286,000
Issuance of common stock and warrants in connection with H Brand acquisition	0	9,611,000
Installment obligations related to acquisition of the Ripka Brand	0	2,190,000
Contingent obligations related to acquisition of the Ripka Brand	0	3,784,000
Supplemental disclosure of cash flow information:
Cash paid during the year for income taxes	453,000	109,000
Cash paid during the year for interest	1,157,000	653,000
Ripka Seller Notes [Member]
Supplemental disclosure of non-cash activities:
Issuance of common stock as payment	5,400,000	0
QVC Earn-Out [Member]
Supplemental disclosure of non-cash activities:
Issuance of common stock as payment	$ 2,515,000	$ 0